Evidence map›Paper›PMID 38907271›Full record

ArticleCardiovascular diabetology2024

Which surrogate insulin resistance indices best predict coronary artery disease? A machine learning approach.

Seyed Reza Mirjalili, Sepideh Soltani, Zahra Heidari Meybodi, Pedro Marques-Vidal, Danial Dehghani Firouzabadi, Reza Eshraghi, David Restrepo, Hamed Ghoshouni, Mohammadtaghi Sarebanhassanabadi

Abstract readComparative Study
In one paragraph

Article in Cardiovascular diabetology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Seyed Reza MirjaliliYazd Cardiovascular Research Center, Non-Communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.ORCID 0000-0001-8568-201X
Sepideh SoltaniYazd Cardiovascular Research Center, Non-Communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.ORCID 0000-0002-1591-2569
Zahra Heidari MeybodiDepartment of Medicine, University of California San Francisco, San Francisco, USA.ORCID 0000-0002-9639-4715
Pedro Marques-VidalDepartment of Internal Medicine, BH10-642, Rue du Bugnon 46, Rue du Bugnon 46, Lausanne, CH-1011, Switzerland.
Danial Dehghani FirouzabadiStudent Research Committee, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.ORCID 0009-0004-9438-7249
Reza EshraghiStudent Research Committee, Kashan University of Medical Sciences, Kashan, Iran.ORCID 0000-0003-3435-3851
David RestrepoLaboratory for Computational Physiology, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID 0000-0002-3789-1957
Hamed GhoshouniRajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Mohammadtaghi SarebanhassanabadiYazd Cardiovascular Research Center, Non-Communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. mtsareban@gmail.com.ORCID 0000-0002-8867-4717

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVarious surrogate markers of insulin resistance have been developed, capable of predicting coronary artery disease (CAD) without the need to detect serum insulin. For accurate prediction, they depend only on glucose and lipid profiles, as well as anthropometric features. However, there is still no agreement on the most suitable one for predicting CAD.

methodsWe followed a cohort of 2,000 individuals, ranging in age from 20 to 74, for a duration of 9.9 years. We utilized multivariate Cox proportional hazard models to investigate the association between TyG-index, TyG-BMI, TyG-WC, TG/HDL, plus METS-IR and the occurrence of CAD. The receiver operating curve (ROC) was employed to compare the predictive efficacy of these indices and their corresponding cutoff values for predicting CAD. We also used three distinct embedded feature selection methods: LASSO, Random Forest feature selection, and the Boruta algorithm, to evaluate and compare surrogate markers of insulin resistance in predicting CAD. In addition, we utilized the ceteris paribus profile on the Random Forest model to illustrate how the model's predictive performance is affected by variations in individual surrogate markers, while keeping all other factors consistent in a diagram.

resultsThe TyG-index was the only surrogate marker of insulin resistance that demonstrated an association with CAD in fully adjusted model (HR: 2.54, CI: 1.34-4.81). The association was more prominent in females. Moreover, it demonstrated the highest area under the ROC curve (0.67 [0.63-0.7]) in comparison to other surrogate indices for insulin resistance. All feature selection approaches concur that the TyG-index is the most reliable surrogate insulin resistance marker for predicting CAD. Based on the Ceteris paribus profile of Random Forest the predictive ability of the TyG-index increased steadily after 9 with a positive slope, without any decline or leveling off.

conclusionDue to the simplicity of assessing the TyG-index with routine biochemical assays and given that the TyG-index was the most effective surrogate insulin resistance index for predicting CAD based on our results, it seems suitable for inclusion in future CAD prevention strategies.

Indexed as

BiomarkersCoronary Artery DiseaseInsulin ResistanceMachine LearningPredictive Value of TestsAdultAgedBlood GlucoseFemaleHumansInsulinMaleMiddle AgedPrognosisRisk AssessmentRisk FactorsBiomarkersBlood GlucoseInsulinCardiovascular diseasesMachine learningMetabolic diseasesPublic Health

Identifiers

PMID38907271
PMCPMC11193173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.